The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predominance of BRCA2 mutation and estrogen receptor-positive breast cancer among BRCA1/2 mutation carriers.
 
Pascal Pujol
Consulting or Advisory Role - AstraZeneca/Merck; Exact Sciences; Pfizer
Speakers' Bureau - AstraZeneca/Merck; Eurofins Biomnis
Research Funding - AstraZeneca/Merck
 
Kévin Yauy
No Relationships to Disclose
 
Amandine Coffy
No Relationships to Disclose
 
Nicolas Duforet-Frebourg
Employment - SeqOne Genomics
 
Sana Gabteni
No Relationships to Disclose
 
Jean-Pierre Daurès
No Relationships to Disclose
 
Frederique Madeleine Penault-Llorca
Consulting or Advisory Role - Abbvie; Agendia; Amgen; Astellas Pharma; AstraZeneca; AstraZeneca (Inst); AstraZeneca/Daiichi Sankyo; BAYER; BMS; Clovis Oncology; Eisai Europe; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Illumina; Janssen; Lilly; Lilly (Inst); MSD; MSD/AstraZeneca; NanoString Technologies; Novartis; Pfizer; Roche; Roche (Inst); SERVIER
Research Funding - Bayer (Inst); MSD (Inst); Myriad Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer (Inst); MSD (Inst); Roche (Inst)
 
Laetitia Collet
No Relationships to Disclose
 
Frédéric Thomas
No Relationships to Disclose
 
Clare Turnbull
No Relationships to Disclose
 
Virginie Galibert
No Relationships to Disclose
 
Chloé Rideau
No Relationships to Disclose
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech
 
David Geneviève
No Relationships to Disclose
 
Kevin S. Hughes
Stock and Other Ownership Interests - CRA Health
Honoraria - Hologic; Myriad Genetics
Consulting or Advisory Role - MedNeon; Targeted Medical Education, Inc.
Other Relationship - Ask2Me
 
Nicolas Philippe
Employment - SeqOne Genomics
Stock and Other Ownership Interests - SeqOne Genomics